Aug 13, 2020
Soliton Introduces Advanced Design for RAP Cartridges
Jun 15, 2020
Soliton Reports Positive Pivotal Cellulite Clinical Trial Results
Jun 09, 2020
Soliton To Announce Results of Pivotal Cellulite Clinical Trial
Apr 08, 2020
Soliton Granted New Key Patent for FDA Cleared RAP Technology
Apr 01, 2020
Soliton Announces New Launch Plan of Next Generation Acoustic Shockwave Product Due to COVID-19
Mar 20, 2020
Lead Investigator Evaluates Next-Step for Soliton Pivotal Cellulite Clinical Data
Mar 02, 2020
Soliton Reports Fourth Quarter and Full Year 2019 Results
Mar 02, 2020
Soliton Reports Fourth Quarter and Full Year 2019 Results
Mar 02, 2020
Soliton Reports Fourth Quarter and Full Year 2019 Results
Jan 27, 2020
Soliton Announces Positive Data from Extended Keloid and Hypertrophic Scar Trials
Jan 13, 2020
Soliton To Announce Keloid and Hypertrophic Scar Clinical 12-Week Trial Data at Maui Derm Meeting
Jan 07, 2020
Soliton Appoints Robert "Joe" Mills as Vice President of Supply Chain
Dec 18, 2019
Soliton Announces Successful Completion of Safety Testing at SGS to Support FDA Filing for Second Generation Device
Nov 21, 2019
Soliton and Emphysys Enter Into a 3-year Development Agreement
Nov 12, 2019
Soliton Announces First Follow-up Visit Conducted in the Pivotal Cellulite Clinical Trial
Oct 29, 2019
Soliton's Recent Positive Data Increases Potential Fibrotic Indications
Oct 08, 2019
Soliton to Announce Keloid and Hypertrophic Scar Clinical Trial Data on October 24, 2019
Oct 03, 2019
Soliton Announces Tattoo Technology Article Published in Medical Journal and Selected as Editor's Choice
Sep 24, 2019
Soliton Announces Majority of Patients Treated in Pivotal Cellulite Trial; Expects All Patients Treated by November 2019
Sep 19, 2019
Soliton Begins Treatments In Proof-Of-Concept Trial For Keloid Scars